The future of vaccines, a dialogue between CCGH & manufacturers

Recent successes, current developments, and future opportunities for vaccines in Germany and globally.

Date
12th November 2026
Location
Hörsaalruine, Campus Mitte, Berlin
Convened By
Charité Center for Global Health (CCGH)
Charité Hörsaalruine - Historic Berlin Medical Lecture Hall
Charité Campus Mitte Historic Architecture

Organised by the Vaccine Theme at the Charité Center for Global Health

The Charité Center for Global Health (CCGH) brings together cross-disciplinary excellence to tackle pressing global health challenges. It's Vaccine Theme bridges discovery, clinical evaluation, real-world post-licensure assessment, and health policy frameworks to maximize immunization impact globally.

Vaccination in Pregnancy

Leading global research on maternal and neonatal immunisation through the international IMPRINT network to protect mothers and babies.

Modelling Impact & Value

Translating trial efficacy into population-level cost-effectiveness and indirect herd effects informing STIKO, JCVI, and WHO SAGE policies.

Translational Immunology (RCi3)

Harnessing the Research Center for Infection, Inflammation and Immunity to understand protective human immune responses for vaccine design.

Clinical Trials & Acceptance

Conducting multicentre GCP trials (MenAfriVac, Pneumosil, nOPV) with MRC Gambia alongside research into healthcare trust and vaccine uptake.

Group discussion at the Charité Center for Global Health
Host Department

Charité Center for Global Health

Fostering collaboration across the vaccine lifecycle.
Photo: Sabine Gudath

A Dialogue Between Science, Industry & Global Policy

The Industry Dialogue aims to offer a neutral, scientific forum where academic leaders, global health specialists, and industry experts exchange breakthroughs in vaccine platforms, explore strategic public-private synergies, and debate policy and market access realities.

View Programme Timetable

Confirmed Speakers

Representatives of six vaccine manufacturers and researchers from the Charité Center for Global Health sharing their perspectives on recent developments and what lies ahead.

Draft Agenda

Thursday, 12th November 2026 • Hörsaalruine, Charité Campus Mitte, Berlin

08:45 - 09:00
Welcome

Arrivals, Welcome & Scene-Setting

Speakers: Stefan Flasche & Beate Kampmann

Introduction to the objectives of the CCGH Industry Dialogue and housekeeping matters.

09:00 - 10:30
Manufacturer's view

Industry Session:
Where we are, where we go & and where we want to be

Session Chair: Joachim Hombach

Rapid-fire 10-minute presentations by industry leaders focusing on recent exciting vaccine developments and upcoming ones, both for Germany and globally.

09:00
Pfizer
Pfizer's respiratory vaccine portfolio: current evidence, open questions, future directions
Christian Theilacker • Christof von Eiff
09:10
GSK
Mission 75% - Shaping the Future of Prevention
Alen Marijam • Corinna Weinhart
09:20
Sanofi
Convincing Stakeholders Through Scientific Evidence – What it Takes Beyond a Vaccine Pipeline
Oliver Damm • Manuel Plomer
09:30
Moderna
mRNA platform, cost effectiveness, new delivery methods
Christian Winkler • (tbc)
09:40
Bavarian Nordic
Vaccines for Public Preparedness and Travel Health
Hubertus Hochrein • Eva Schalk
09:50
MSD
From Innovation to Impact: Why the Next Challenge in Vaccines Is Implementation
Thorsten Christian Reuter • Vanessa Lipp
10:00
Panel discussion
Joint Q&A and moderated discussions on the future of vaccines
One speaker from each presentation
10:30 - 11:00
Refreshments

Coffee Break & Networking

Networking refreshments served in the foyer of the Hörsaalruine. Connect with delegates, session chairs, and audience.

11:00 - 12:30
CCGH's view

Charité Center for Global Health Session:
Research along the vaccine lifecyle

Session Chair: Joachim Hombach

Short presentations showcasing vaccine research at Charité, covering antigen discovery, post-licensure evaluation, health economics, emerging pathogens, and global policy.

11:00
Discovery Research
Antigen discovery and translational immunology (tbc)
Tomislav Kostevc
11:15
Clinical Evaluation
Licensing and post-licensure vaccine studies at Charité
Leif Erik Sander
11:30
Measuring / Predicting Impact
The value of vaccines in Germany
Julia Mayer • Lucy Ingaiza
11:40
Vaccines for Emerging Pathogens
Considerations for Oropouche virus vaccines
Felix Drexler
11:50
Policy Translation
Connecting Global Health Policy
Branwen Hennig
12:00
Panel discussion
Joint Q&A and moderated discussions on the future of vaccines
All speakers in this session
12:30 - 14:00
Lunch & Close

Closing Remarks & Networking Lunch

Remarks by: Beate Kampmann & Stefan Flasche

Summary of key outcomes and next collaborative milestones, followed by a catered networking lunch in the venue foyer.

Hörsaalruine (Lecture Hall Ruin)

The Berliner Medizinhistorisches Museum's Hörsaalruine on the Campus Mitte is one of Berlin's most distinctive event venues. Originally the Rudolf Virchow lecture theatre it was destroyed during World War II. Its exposed brick and raw architectural character provide a vivid historical grounding for discussing the future vaccine innovation.

Public Transit U-Bahn: U6 (Oranienburger Tor / Naturkundemuseum) • S-Bahn / Regional: Berlin Hauptbahnhof & Friedrichstraße
Schedule Doors open at 08:30 • Program begins promptly at 08:45
Charité Hörsaalruine in session
Campus Mitte • Charité – Universitätsmedizin Berlin
Registration Placeholder • current not yet open

Registration

Attendance at the Hörsaalruine is capped due to venue capacity. Pre-register your interest and the secretariat will contact you with further details.